About Us

PeptideGuider.com is an independent informational resource covering research peptides. We publish evidence-based editorial content on peptide compounds, their regulatory status across major jurisdictions, vendor due-diligence frameworks, and compound comparisons – all from an independent editorial perspective.

We are not a peptide vendor. We do not sell peptides, facilitate peptide transactions, or maintain commercial relationships with any peptide supplier. We do not provide medical advice, dosing protocols, or treatment recommendations. PeptideGuider.com exists purely as an informational resource for readers who want to understand the peptide landscape through credible, independently produced content.

The peptide information landscape has a credibility problem. The majority of content available online is produced or funded by vendors with an obvious commercial interest in presenting their products favourably. Blog posts written by the companies selling the compounds, “educational” articles that conveniently link to a storefront, influencer endorsements with undisclosed sponsorship arrangements – the conflicts of interest are pervasive and rarely acknowledged.

PeptideGuider.com was built to fill a gap that should not exist: an independent editorial voice in a space dominated by vendor marketing dressed up as journalism. We cover peptides the way any legitimate subject deserves to be covered – with transparency about what the evidence actually says, honest acknowledgement of what remains uncertain, and zero commercial incentive to spin the facts in any particular direction.

Every article published on PeptideGuider.com is guided by three editorial principles:

• Evidence-based. Claims are grounded in regulatory filings, peer-reviewed research, clinical trial data, and primary source documentation. We do not repeat vendor marketing claims as fact.
• Regulatory-aware. Peptide legality and approval status varies significantly between the US, UK, Australia, and other jurisdictions. We cover regulatory reality as it stands, not as vendors wish it were.
• Transparent. Where evidence is limited, conflicting, or absent, we say so. We do not fill gaps in the research record with speculation presented as certainty.

Our research process draws from primary and secondary sources that meet a clear credibility threshold:

• Regulatory databases and filings from the FDA, MHRA, and TGA
• PubMed and peer-reviewed biomedical literature
• Clinical trial registries (ClinicalTrials.gov, EU Clinical Trials Register)
• Regulatory dockets, enforcement actions, and import alerts
• Published expert commentary and institutional guidance

We do not treat vendor marketing materials, social media testimonials, or influencer endorsements as credible source material. These may be referenced as examples of industry claims, but never as evidence supporting those claims.

No peptide vendor, supplier, or manufacturer pays for placement on PeptideGuider.com or influences our editorial coverage in any way. We do not accept sponsored content, paid reviews, or commercially motivated editorial direction. Our coverage is determined entirely by editorial judgement and reader interest.